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Abstract. 
 
Members of the synaptobrevin/VAMP fam-
ily of v-SNAREs are thought to be essential for vesicle 
docking and exocytosis in both lower and higher eu-
karyotes. Here, we describe yeast mutants that appear 
to bypass the known v-SNARE requirement in secre-
tion. Recessive mutations in either 
 
VBM1
 
 or 
 
VBM2
 
, 
which encode related ER-localized membrane proteins, 
allow yeast to grow normally and secrete in the absence 
of Snc v-SNAREs. These mutants show selective alter-
ations in protein transport, resulting in the differential 
trafficking and secretion of certain protein cargo. Yet, 
processing of the vacuolar marker, carboxypeptidase Y, 
and the secreted protein, invertase, appear normal in 
these mutants indicating that general protein traffick-
ing early in the pathway is unaffected. Interestingly, 
 
VBM1
 
 and 
 
VBM2 
 
are allelic to 
 
ELO3 
 
and 
 
ELO2
 
, two 
genes that have been shown recently to mediate the 
elongation of very long chain fatty acids and subse-
quent ceramide and inositol sphingolipid synthesis. 
Thus, the v-SNARE requirement in constitutive exocy-
tosis is abrogated by mutations in early components of 
the secretory pathway that act at the level of lipid syn-
thesis to affect the ability of secretory vesicles to sort 
and deliver protein cargo.
Key words: Snc proteins ¥ SNAREs ¥ synaptobrevin 
¥ sphingolipids ¥ ceramides ¥ exocytosis
 
P
 
rotein
 
 transport between organelles relies upon
carrier vesicles that bud from one compartment
and fuse selectively with another. This process is
thought to be fundamental to both the functioning of the
secretory pathway, as well as its overall organization.
Therefore, organelle-specific trafficking of vesicles re-
quires specialized proteins that regulate their transport,
docking, and fusion. Many of these proteins have been
identified and studies from both simple and higher eukary-
otes suggest that their modes of action have remained con-
served in evolution (Bennett and Scheller, 1993; Ferro-
Novick and Jahn, 1994; Rothman, 1994).
The current model for how transport vesicles are thought
to recognize their acceptor compartments relies upon ge-
netic and biochemical studies that reveal that specific
membrane-localized receptors (termed SNAREs)
 
1
 
 are
present on both donor and acceptor compartments (Sll-
ner et al., 1993
 
a
 
,
 
b
 
 and reviewed in Rothman and Warren,
1994). Complex formation between SNAREs of the donor
(or vesicular) compartment (v-SNAREs) with those of the
acceptor (or target) compartment (t-SNAREs) is thought
to be necessary and sufficient to confer vesicle docking.
Initially, formation of the SNARE complex was proposed
to be a prerequisite for assembly of a prefusion particle
that included the soluble 
 
N
 
-ethylmaleimide-sensitive fu-
sion protein (NSF) and its attachment proteins (SNAPs),
that are recruited from the cytosol. Subsequent hydrolysis
of ATP by NSF was found to result in disassembly of the
SNARE complex in vitro and was suggested to lead di-
rectly to membrane fusion (Sllner et al., 1993
 
a
 
,
 
b
 
 and re-
viewed in Rothman and Warren, 1994). As compartment-
specific v- and t-SNAREs have been found at nearly every
level of the secretory pathway, the universality of this
model has been generally accepted. Yet, later studies on
vacuolar membrane fusion
 
 
 
in vitro
 
 
 
have shown that NSF/
SNAP may act before SNARE assembly (Mayer et al.,
1996) and mediate upstream events that result in priming
of the t-SNARE component involved in homotypic fusion
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1. 
 
Abbreviations used in this paper:
 
 HDSV, high density secretory vesicles;
IPC, inositol-phosphorylceramide; LCFA, long chain fatty acid; LDSV,
low density secretory vesicles; MIPC, mannose inositol-phosphorylcer-
amide; M(IP)
 
2
 
C, mannose (inositolphosphoryl)
 
2
 
-ceramide; NEM, 
 
N
 
-eth-
 
ylmaleimide; NSF, NEM-sensitive fusion protein; PI, phosphoinositide;
SC, synthetic minimal medium; SNAP, soluble NSF attachment protein;
SNARE, SNAP receptor; VAMP, vesicle-associated membrane protein;
VBM, v-SNARE bypass mutants; YPD, yeast extract/peptone/dextrose.
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(Xu et al., 1998). Moreover, it was demonstrated that to-
gether v- and t-SNAREs are necessary and sufficient for
conferring both membrane association and bilayer fusion,
using a liposome-based in vitro
 
 
 
assay (Weber et al., 1998).
Thus, the requirements for bilayer fusion, as originally
proposed (Sllner et al., 1993
 
a
 
,
 
b
 
) may differ at the or-
ganellar level. This idea is supported by additional studies
that show that organelle fusion is t-SNARE-dependent
and occurs in the absence of a v-SNARE partner (Nichols
et al., 1997; Patel et al., 1998).
Previously, we have shown that yeast possess two homo-
logues of the synaptobrevin/VAMP family of v-SNAREs,
named Snc1 and Snc2 (Gerst et al., 1992; Protopopov et al.,
1993). These proteins are components of post-Golgi exo-
cytic vesicles and are required for normal cellular secre-
tion and viability (Protopopov et al., 1993). Like their ver-
tebrate homologues, Snc proteins form complexes with
t-SNAREs from the plasma membrane, including Sec9
(SNAP-25 homologue; Brennwald et al., 1994) and the Sso
proteins (syntaxin 1A, B homologues; Aalto et al., 1993).
Snc proteins coprecipitate with these t-SNAREs from cell
lysates (Brennwald et al., 1994; Couve and Gerst, 1994)
and the 
 
SNC 
 
genes interact genetically with genes whose
products contribute to formation of the exocytic SNARE
complex, including: 
 
SEC9
 
, 
 
SSO1/2
 
, and 
 
SEC17
 
 (
 
a
 
-SNAP
homologue; Couve and Gerst, 1994; Gerst, 1997). Along
with a recent study that demonstrates formation of a Snc1-
Sso1-Sec9 ternary complex in vitro (Rossi et al., 1997), this
suggests that the neuronal and yeast exocytic SNARE
complexes are highly similar. Thus, the Snc1/2, Sso1/2, and
Sec9 proteins are archetypal v- and t-SNARE elements
that have evolved from conferring constitutive exocytosis
in lower eukaryotes to mediate both constitutive and stim-
ulus-coupled secretion in higher organisms.
Earlier, we described null mutations in the 
 
SNC
 
 genes as
resulting in a conditional lethal phenotype. 
 
snc
 
 yeast are
temperature sensitive, unable to grow on amino acidÐrich
medium, fail to undergo cell wall separation after cytoki-
nesis, accumulate post-Golgi secretory vesicles, and are
defective in invertase secretion (Protopopov et al., 1993).
Yet, such cells are viable and grow slowly on synthetic
minimal medium and at temperatures 
 
#
 
30
 
8
 
C. Somehow,
 
snc
 
 cells maintain a level of secretion competence, despite
the complete absence of these v-SNAREs. Thus, an un-
known mechanism must allow yeast lacking exocytic
v-SNAREs to deliver lipids and proteins to the cell surface
to maintain cell growth and division.
Here, we have isolated spontaneous revertants of 
 
snc
 
cells and show that recessive mutations in two genes, des-
ignated as 
 
VBM1
 
 and 
 
VBM2
 
, allow cells to become tem-
perature-resistant, grow normally, and to secrete selected
cargo molecules efficiently in a Snc v-SNARE-indepen-
dent fashion. Interestingly, cells bearing these mutations,
designated here as v-SNARE bypass mutants (VBMs),
also show a selective recoupling of the exocytic pathway,
such that some protein cargo is trafficked efficiently in one
mutant class, while accumulating in another. This selectiv-
ity suggests that the late secretory pathway in yeast is
bifurcated, as first proposed by Harsay and Bretscher
(1995), but also that the alternate routes to the cell surface
may be distinctly modulated. As 
 
VBM1 
 
and 
 
VBM2
 
 are al-
lelic to 
 
ELO3
 
 and 
 
ELO2
 
, two genes with overlapping
functions that are involved in long chain fatty acid
(LCFA) elongation and sphingolipid synthesis, we suggest
that ceramide and sphingolipid metabolism may prove to
be an important determinant in protein sorting and the
trafficking of secretory vesicles in yeast.
 
Materials and Methods
 
Media and Genetic Manipulations
 
Yeast were grown in media containing 2% glucose or 3.5% galactose.
Amino acidÐrich yeast extract/peptone/dextrose medium (YPD), syn-
thetic minimal medium (SC), and SC drop-out medium, lacking an essen-
tial amino acid or nucleotide base, were used. Media were prepared simi-
lar to that described by Rose et al. (1990). Standard methods were used
for the introduction of DNA into yeast, the preparation of genomic DNA,
and for tetrad dissection (Rose et al., 1990). Growth assays were per-
formed as described (Gerst et al., 1991).
 
Plasmids
 
Vectors included: YEp13M4, a 2
 
m
 
 plasmid that bears a 
 
LEU2
 
 selectable
marker and pAD4
 
D
 
, a similar plasmid that contains the 
 
ADH1
 
 constitu-
tive promoter. Centromeric vectors included: pSE358, which bears a
 
TRP1
 
 marker; pRS315, which bears a 
 
LEU2 
 
marker; and pAD11, which
bears the 
 
ADE2
 
 and 
 
HIS3
 
 markers. Previously described plasmids in-
cluded: pADH-SNC1 (Gerst et al., 1992) and pTGAL-SNC1 (Protopopov
et al., 1993).
Constructs created included: pTADH-SNC1, which contains a BamHI
fragment bearing the 
 
ADH1-SNC1
 
 construct from pADH-SNC1 cloned
into pSE358. Constructs for the expression of 
 
VBM1
 
/
 
SUR4
 
 and 
 
VBM2
 
/
 
GNS1 
 
were created by PCR. Oligonucleotides designed to prime up-
stream and downstream to the various genes were used in the PCR re-
action. All PCR-generated fragments bore encoded SalI and SacI sites
that were used for subcloning into 2
 
m
 
 vectors, pAD4
 
D
 
 and YEp13M4 to
give: pADH-SUR4/VBM1 and YEpGNS1/VBM2; into pRS315 to give
YCpSUR4/VBM1; and into pSE358 to give YCpGNS1/VBM2. A frame-
shift mutation in 
 
SUR4
 
/
 
VBM1
 
 was created using a mutant forward oligo-
nucleotide that encodes a termination signal after the third codon. This
was cloned into pAD4
 
D
 
 to yield pADH-SUR4FS. Tagged 
 
VBM 
 
genes
were created using reverse primers that encoded the HA epitope. These
PCR products were subcloned into pRS315 to give YCpVBM1HA and
YCpVBM2HA, and into pAD4
 
D
 
 to yield pADH-VBM1HA. Disruption
constructs for 
 
SUR4
 
/
 
VBM1
 
 and 
 
GNS1
 
/
 
VBM2
 
 were created by inserting
 
TRP1 
 
and 
 
LEU2 
 
markers either into the StyI and BlpI sites of 
 
SUR4
 
, or
the EcoRV site of 
 
GNS1
 
, via blunt-end ligations, to give pVBM1T,
pVBM2T, pVBM1L, and pVBM2L, respectively. Plasmid pAHGAL-
SNC2, which contains 
 
SNC2
 
 under control of the 
 
GAL
 
 promoter, was cre-
ated by subcloning the appropriate EcoRV-SacI fragment of pGAL-
SNC2 (Protopopov et al., 1993) into the SmaI-SacI sites of pAD11. A
 
HIS3 
 
disruption construct for 
 
SNC2
 
,
 
 
 
pSNC2H, was created by subcloning
a BamHI fragment of 
 
HIS3 
 
into the BglII site of a 3-kb genomic fragment
bearing 
 
SNC2, 
 
carried in plasmid
 
 
 
p2H (Couve and Gerst, 1994). The 
 
snc2::
HIS3
 
 fragment was released by digestion with BspHI and used in transfor-
mations. All constructs were verified by restriction analysis.
 
Immunofluorescence and Immunoblot Analysis
 
Cell lysates were prepared as described (Couve and Gerst, 1994). Lysates
and vesicle preparations were transferred to nitrocellulose membranes for
detection. For immunofluorescence, fixed yeast spheroplasts were perme-
abilized with 0.5% SDS, incubated with antibodies, and visualized by con-
focal microscopy. Affinity-purified antisera included: anti-Dpm1 (Molec-
ular Probes), anti-HA (12CA5), anti-Mnn1 (gift of S. Emr, Howard
Hughes Medical Institute, University of California, San Diego, CA), and
anti-Sso (gift of P. Brennwald, Cornell University Medical College, New
York, NY). FM4-64 labeling was carried out, essentially as described
(Vida and Emr, 1995).
 
Yeast Strains
 
Wild-type strains included: W303-1a (
 
Mat
 
a 
 
can1 his3 leu2 lys2 trp1 ura3
ade2
 
), W303-1b (
 
Mat 
 
a
 
 
 
can1 his3 leu2 lys2 trp1 ura3 ade2
 
), and SP1 (
 
Mat
 
a 
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leu2 ura3 trp1 ade8 can1 his3
 
). Other strains included: NY778 (
 
Mat
 
 
 
a
 
 
 
leu2-
3,112 ura3-52 sec6-4
 
), NY782 (
 
Mat
 
a 
 
leu2-3,112 ura3-52 sec9-4
 
; Walworth
et al., 1992), H603 (
 
Mat
 
a 
 
can1 leu2 trp1 ura3 ade2
 
 
 
sso1
 
D
 
::HIS3 sso2-1
 
;
Gerst, 1997), and JG8 T15:85 (
 
Mat
 
a 
 
his3 leu2 trp1 snc1::URA3 snc2::
ADE8
 
 pGAL-SNC1 or pTGAL-SNC1; Protopopov et al.,
 
 
 
1993). A 
 
Mat
 
 
 
a
 
strain of JG8 T15:85, JG8 T15:85
 
a
 
, was generated by mating-type switch-
ing. Mutant strains analyzed in this study included: 
 
vbm1-1
 
 (JG8R-A14;
 
Mat
 
a 
 
his3 leu2 trp1 snc1::URA3 snc2::ADE8
 
 
 
vbm1-1
 
), 
 
vbm2-1
 
 (JG8R-
 
a
 
39; 
 
Mat
 
 
 
a
 
 
 
his3 leu2 trp1 snc1::URA3 snc2::ADE8
 
 
 
vbm2-1
 
) and 
 
vbm2-2
 
(JG8R-
 
a
 
10; 
 
Mat
 
 
 
a
 
 
 
his3 leu2 trp1 snc1::URA3 snc2::ADE8
 
 
 
vbm2-2
 
). 
 
VBM
 
disruption strains in the 
 
snc 
 
background included: DD1 (
 
Mat
 
a 
 
his3 leu2
snc1::URA3 snc2::ADE8
 
 
 
vbm1::TRP1
 
) and SS1 (
 
Mat
 
a  his3 leu2 snc1::
URA3 snc2::ADE8 vbm2::LEU2), which were created by transformation
of JG8 cells with the appropriate disruption constructs. A snc sso1D sso2-1
strain (JG9-S2) was created by transformation of a sso1::HIS3 sso2-1 hap-
loid segregant (derived from a cross between H603 and W303-1b) with
plasmid pAHGAL-SNC2, followed by the sequential disruption of SNC1
and SNC2. Cells were maintained continually on galactose-containing me-
dium to prevent lethality. Next, the disruption of VBM1 or VBM2 in JG9-
S2 cells was accomplished by transformation using the appropriately di-
gested pVBM1T and pVBM2T plasmids. Strains: JG9-S2V1 (Mata ade2
snc1::URA3 snc2::LEU2 vbm1::TRP1 sso1::HIS3 sso2-1) and JG9-S2V2
(Mata ade2 snc1::URA3 snc2::LEU2 vbm2::TRP1 sso1::HIS3 sso2-1) were
obtained in this fashion. VBM disruptions in the sec6-4 and wild-type
backgrounds yielded strains: DD2 (Mat a ura3-52 sec6-4 vbm1::LEU2),
SS2 (Mat a ura3-52 sec6-4 vbm2::LEU2), and SS3 (Mata ura3 trp1 ade8
can1 his3 vbm2::LEU2). Disruptions were accomplished by transforma-
tion of the sec6-4 and SP1 strains using a fragment obtained from diges-
tions of the pVBM1L and pVBM2L plasmids. All disruptions were veri-
fied by Southern or PCR analyses.
Thin-sectioning and Electron Microscopy
The fixation, thin-sectioning and electron microscopy of yeast was per-
formed as described previously (Zelicof et al., 1996). Uranyl acetate stain-
ing of membranes from density gradients was performed by first diluting
the three fractions of a given peak of enzymatic activity in the gradient
buffer (Harsay and Bretscher, 1995) lacking Nycodenz, followed by the
addition of glutaraldehyde to a final concentration of 3%. After 2Ð4 h
with shaking, the membranes were pelleted at 100,000 g and resuspended
in 20 ml of buffer. Next, grids bearing collodium support film were incu-
bated with the membranes for 1 min, followed by staining with 1% uranyl
acetate (1 min). Membranes were visualized by electron microscopy.
Secretion of Media Proteins and PulseÐChase Analysis
The secretion of proteins into the medium was measured using the
method of Gaynor and Emr (1997). Intracellular protein processing was
monitored by pulseÐchase analysis using 35[S]methionine (Amersham Inc.,
Princeton, NJ), as described (Couve et al., 1995). Anti-CPY (gift of S.
Emr), anti-invertase (gift of E. Bibi, Weizmann Institute of Science, Re-
hovot, Israel), and anti-Gas1 (gift of R. Schekman, University of Califor-
nia, Berkeley, CA) antibodies were used in the immunoprecipitation reac-
tions. Autoradiography was performed using a fluorescence enhancer.
Vesicle Preparations and Density
Gradient Centrifugation
Vesicle preparations and density gradient centrifugation were performed,
as described by Harsay and Bretscher (1995). sec6 or sec9 cells were tem-
perature-shifted to 378C for 1Ð2 h before harvesting, while snc vbm and
snc cells were maintained at 268C. snc cells were shifted to phosphate-
depleted synthetic medium to induce acid phosphatase, unlike sec6 cells
that were shifted to phosphate-depleted YPD. In other experiments, sec6
or sec9 cells were incubated for 2 h in low glucose (0.05%) YPD, before
temperature-shifting, to induce invertase expression.
15Ð30% Nycodenz gradients were prepared and collected using a
Buchler Autodensi-Flow IIc gradient builder. Fractions from the gradient
(z700 ml) were aliquoted and frozen at 2708C, until use. Samples were
taken to determine protein concentration, using the Bradford protein dye
binding assay (Bio-Rad), and density.
Enzymatic Assays
Acid phosphatase and exoglucanase were assayed by the methods of Van
Rijn et al. (1972) and Santos et al. (1979), respectively, as described in
Harsay and Bretscher (1995). Activity is expressed in arbitrary units based
upon the absorbance measured at 415 nm. ATPase activity was assayed by
using method of Bowman and Slayman (1979), with some modifications of
its application described in Harsay and Bretscher (1995). First, substrate
concentration was modified to 2 mM ATP, as higher concentrations result
in an elevated background. Second, blanks were measured to determine
the rate of endogenous ATP hydrolysis and were subtracted from values
obtained with samples from the gradient. Detection of inorganic phos-
phate was assayed by the method of Ames (1966). Optical density was
measured after 10 min and the activity expressed in arbitrary units, based
upon absorption at 820 nm. Invertase activity was assayed by the method
of Goldstein and Lampen (1975) and is expressed either in arbitrary units,
based upon absorption at 540 nm, or in units, where 1 unit 5 1 mmol glu-
cose released/min/100 mg of dry cells.
Metabolic Labeling of Sphingolipids
Yeast cells grown to log phase in SC medium were pulsed for 30 min with
3H-myo-inositol (1 mCi/OD unit), followed by a chase for 90 min. After-
wards, yeast were lysed and equivalent amounts of protein were extracted
with CHCl3:CH3OH:H2O (10:10:3). The organic phase was removed and
split, whereby half was untreated, while the rest was treated with alkali
(0.2 N KOH in CH3OH) to hydrolyze the phosphoinositides and then
neutralized with acetic acid. Both sets of extracts were dried, resuspended
in CHCl3:CH3OH (1:1), and subjected to thin-layer chromatography on
Silica gel 60 plates (Merck, Darmstadt, Germany), using CHCl3:CH3OH:
0.25% KOH (55:45:10) as solvent to separate the inositol-labeled lipids. A
Fuji BAS1000 phosphorimager and BAS-TR2040S screen was used in the
imaging and quantitation of the labeled lipids.
Results
Isolation of v-SNARE Bypass Mutants
Because snc null mutations greatly reduce cellular secre-
tion and viability, we examined whether other yeast pro-
teins could recouple exocytosis and restore full viability in
the absence of Snc protein. We screened multi-copy gene
libraries in snc yeast and isolated colonies that were tem-
perature-resistant and able to grow on YPD media in a
plasmid-dependent manner. Subsequent analysis of the
z70 clones isolated revealed that all encoded either SNC1
or SNC2 (data not shown). Thus, it seems unlikely that
other yeast proteins can substitute for the Snc v-SNAREs
and confer normal constitutive secretion. In addition, simi-
lar experiments using v-SNAREs involved in ERÐGolgi
transport, Bet1 and Bos1 (Dascher et al., 1991; Shim et al.,
1991; Newman et al., 1992), as well as rat VAMP1 or
VAMP2 (Baumert et al., 1989; Elferink et al., 1989) failed
to show suppression of the snc phenotypes (Gerst, 1997
and unpublished data).
To isolate chromosomal suppressors for the snc null
phenotype, we plated snc yeast (which carry a galactose-
inducible SNC1 gene and are maintained normally on ga-
lactose-containing medium) onto YPD plates and allowed
for the occurrence of spontaneous revertants. YPD-resis-
tant cells arose at a frequency of .1:105, were morphologi-
cally indistinguishable from wild-type cells, and were tem-
perature resistant (data not shown). We examined 100
revertants from both mating types and determined their
genetic disposition. Nearly all (98%) mutants appeared to
have undergone recessive mutation, as back-crossing to the
parental snc cells resulted in failure of the diploids to grow
on YPD. Next, by Western analysis, we examined whether
Snc protein expression had been restored. We found that
45% of the revertants expressed Snc1, indicating that they
underwent mutation to restore protein expression fromThe Journal of Cell Biology, Volume 143, 1998 1170
the galactose-inducible promoter. Nevertheless, over half
the cells did not express Snc protein and were able to lose
the plasmid-borne copy of GAL-SNC1 without any loss in
cellular viability. Such cells appear to bypass the v-SNARE
requirement in exocytosis and were designated as VBMs.
Complementation analysis showed that the recessive
mutations fall into two groups, representing two genes
designated here as VBM1 and VBM2. Out of 50 mutants
examined, roughly one-quarter were found to be vbm1,
whereas the rest were vbm2. The VBM phenotype was
found to segregate 2:2 in meiotic segregants derived from
crosses with snc cells (data not shown).
Differential Secretion of Invertase by vbm1 and
vbm2 Cells
Since v-SNARE bypass mutants grow like wild-type yeast,
we examined their ability to secrete proteins. We first ex-
amined their ability to secrete invertase, an enzyme used
as a standard for studying secretion competence, and
whose secretion is essentially blocked in snc cells (Proto-
popov et al., 1993; Gerst, 1997). We found that snc vbm1
cells were unable to secrete invertase at 378C, unlike either
wild-type or snc vbm2 cells, but much like sec6 cells shifted
to nonpermissive conditions (Fig. 1 A, left). Cells bearing
temperature-sensitive mutations in late-acting sec genes
(i.e., SEC6) are known to be deficient in invertase secre-
tion when shifted to the nonpermissive temperature (e.g.,
378C; Novick et al., 1980; Walworth et al., 1988). In con-
trast, snc vbm2 cells secreted z50% of newly synthesized
invertase, which was more similar to the wild-type SP1
cells that secreted 75% (Fig. 1 A).
Interestingly, we found that snc vbm1 cells were capable
of secreting some invertase at lower temperatures (e.g.,
268C; Fig. 1 A, right). We found that snc vbm1 cells se-
creted z40% of newly synthesized invertase in several ex-
periments (Fig. 1 A and data not shown). Under these
same conditions, though, snc vbm2 cells were found to se-
crete invertase more efficiently and secreted z70% of
newly synthesized invertase (Fig. 1 A and data not shown).
snc control cells were found to synthesize and secrete only
small amounts of enzyme. Thus, while snc vbm1 and snc
vbm2 cells grow in an identical fashion, they secrete in-
vertase differentially and in a temperature-dependent
fashion.
We also determined whether SNC gene expression from
a single-copy plasmid could restore invertase secretion
from snc vbm1 cells at 378C (Fig. 1 A, middle). As ex-
pected, Snc1 expression conferred secretion competence
to snc vbm1 cells and also improved secretion from snc
vbm2 cells. Under these conditions, both snc vbm1 and snc
vbm2 cell types secreted z75% of newly synthesized in-
vertase. Therefore, reexpression of the exocytic v-SNARE
restored invertase secretion from snc vbm cells to wild-
type levels.
Restored Secretion of Media Proteins by vbm Mutations
Whereas some secreted proteins remain within the peri-
plasm, many are released into the growth medium (Robin-
son et al., 1988 and Gaynor and Emr, 1997). To determine
whether the secretion of these proteins occurs efficiently
in snc and snc vbm cells, we examined the secretion of me-
dia proteins at 26 and 378C, using pulseÐchase labeling
(Fig. 1 B and data not shown). The results shown in Fig. 1
B are from a representative experiment performed at
268C. Identical results were obtained from strains shifted
to 378C (1Ð2 h). After gel electrophoresis and autoradiog-
raphy, we found that wild-type SP1 cells released at least
9Ð10 labeled proteins into the media, as shown previously
for another wild-type strain (Gaynor and Emr, 1997). In
contrast, snc cells secreted reduced amounts of these pro-
teins (e.g., 20Ð30% of SP1 cells, on average) and showed
differential patterning (Fig. 1 B). The highest molecular
weight band, which corresponds to HSP150 (Gaynor and
Emr, 1997), was elevated between two- and fivefold, de-
Figure 1. Secretion of invertase and media proteins from v-SNARE bypass mutants. (A) Invertase secretion was followed in wild-type
(WT), sec6, snc, snc vbm1, and snc vbm2 cells that were maintained at 268C or temperature-shifted to 378C for 2 h (to induce vesicula-
tion in sec6 cells). Values for cells derepressed on low glucose medium are shown. NS represents the nonsecreted enzyme activity, mea-
sured from lysed spheroplasts. S indicates the secreted enzyme, measured from untreated cells. Values are given in units (1 unit 5 1
mmol glucose released/min/100 mg of dry cells). Cells in the panel marked 378C express native levels of Snc protein, where appropriate.
Cells in the panel marked 378C, pTADH-SNC1 include snc vbm cells that bear a single-copy plasmid that expresses SNC1 constitutively.
(B) Secreted media proteins were precipitated from snc, wild-type (SNC), vbm1, or vbm2 cells that were pulseÐchase labeled with
[35S]methionine at 308C. Molecular mass is given in kilodaltons (kD). The filled-in circles designate those proteins routinely identified
from the culture medium of wild-type cells.David et al. v-SNARE-independent Exocytosis in Yeast 1171
pending upon the experiment. In contrast, some bands
(i.e., at 33, 37, and 39 kD) were barely detectable or were
missing altogether (e.g., at $100 kD) from the culture me-
dium of snc cells.
Mutations in the VBM genes restored the secretion of
proteins into the medium from snc cells. Both snc vbm1
and snc vbm2 cells had a secretion profile basically similar
to that of wild-type cells and secreted a similar amount of
protein into the medium, as deduced by autoradiography
(Fig. 1 B) and scintillation counting (data not shown). Lev-
els of the different proteins, as well as the number of
bands, did vary somewhat from experiment to experiment.
The reason for these differences is unclear. Identical re-
sults were obtained at 378C (data not shown), indicating
that the restoration in media protein secretion from snc
cells is temperature-independent.
Intracellular Processing of CPY and Invertase Is 
Normal, but That of the GPI-anchored Protein, Gas1, Is 
Retarded in snc vbm Cells
Because snc vbm cells secrete invertase differentially, we
examined the intracellular trafficking of other proteins by
35S-methionine labeling and pulseÐchase analysis at 30 and
378C. First, we found that carboxypeptidase Y (CPY), a
vacuolar hydrolase that reaches maturation upon trans-
port to the vacuole, is not secreted from snc vbm cells and
is found solely in its mature form in yeast grown to mid-log
phase, as determined by Western analysis (data not
shown). PulseÐchase labeling experiments also revealed
that CPY underwent normal processing to its mature (m)
form in snc vbm cells at both 30 and 378C, like wild-type
yeast (Fig. 2 A). We note that in snc cells, unlike wild-type
or snc vbm cells, this processing is incomplete within 45
min at 308C and that some protein remains in the p2 form.
This is further exacerbated at restrictive conditions (378C),
which result in an even greater proportion of CPY in its
immature p1 and p2 forms. Thus, mutations in the VBM
genes restore the normal rate of processing of CPY to snc
cells.
Other pulseÐchase experiments demonstrated that the
secreted enzyme, invertase, is processed to its glycosylated
higher molecular weight forms in snc vbm cells, as shown
for both snc and wild-type yeast at 30 and 378C (Fig. 2 B).
Thus, both trafficking of CPY to the vacuole and the pro-
cessing of invertase in the VBM cells are similar to that
found in wild-type yeast, suggesting that protein traffick-
ing along early stages of the pathway is unaffected. In ad-
dition, we also examined uptake of fluorescent dyes (i.e.,
FM4-64) that are internalized via the endocytic pathway
and label the yeast vacuole. We found no qualitative de-
fects in dye uptake and vacuolar labeling in either snc vbm
cell type, suggesting that the endocytic pathway is not sig-
nificantly affected in these mutants.
In contrast, pulseÐchase analysis did show that the kinet-
ics of maturation for the GPI-anchored protein, Gas1,
were slowed in snc vbm cells, in comparison to wild-type
cells, in particular at 378C (Fig. 2 C). Whereas Gas1 was
Figure 2. Processing of CPY, invertase, and Gas1 in snc, snc vbm,
and wild-type yeast cells. The intracellular processing of carboxy-
peptidase Y (A), invertase (B), and Gas1 (C) was followed in
wild-type (WT), snc, snc vbm1, and snc vbm2 cells that were
maintained at 308C or temperature-shifted to 378C (1 h), by
pulseÐchase analysis. Cells were labeled with [35S]methionine
(pulse) followed by the addition of fresh medium containing un-
labeled excess methionine and cysteine (chase). Samples were re-
moved at various times; cellular proteins were extracted, immu-
noprecipitated using specific antibodies, electrophoresed, and
autoradiographed as described (Couve et al., 1995). Molecular
masses are given in kilodaltons (kD).The Journal of Cell Biology, Volume 143, 1998 1172
found in its mature form by 30 min in wild-type cells, this
was not true in either snc or snc vbm cells, which still
showed Gas1 in its immature form after 45 min. This dif-
ference was more prominent at high temperature (378C)
and showed that z40Ð50% of the protein had not under-
gone maturation. Thus, unlike CPY or invertase, the traf-
ficking of the GPI-anchored protein, Gas1, is not restored
by mutations in the vbm genes.
Differential Accumulation of Secretory Vesicles in snc 
vbm Cells
As invertase is secreted efficiently by snc vbm2 cells, but
not snc vbm1 cells, we examined both VBMs by electron
microscopy. Unlike wild-type cells, VBMs were found to
accumulate 50Ð100-nm transport vesicles, the approximate
size of post-Golgi secretory vesicles (Fig. 3). This is similar
to that shown previously for snc cells (Protopopov et al.,
1993), however, snc vbm1 cells accumulate vesicles prima-
rily in the bud (Fig. 3 a), while snc vbm2 cells accumulate
vesicles in both mother and bud (Fig. 3 c). The distribution
of vesicles in snc vbm2 cells is similar to that seen with snc
cells (Protopopov et al., 1993), although snc cells accumu-
late greater numbers of vesicles (data not shown). Aside
from the accumulation of vesicles seen in the snc vbm mu-
tants, no additional morphological abnormalities were ob-
served.
Next we determined whether the restoration of SNC
gene expression could abolish vesicle accumulation in
VBM cells. As predicted from the invertase secretion ex-
periments (Fig. 1 A), restoration of SNC1 expression
blocked vesicles from accumulating in either snc vbm1 or
snc vbm2 cells (Fig. 3, b and d, respectively), as evidenced
by electron microscopy. Thus, the reexpression of Snc pro-
tein in snc vbm cells recouples both invertase secretion
and vesicle transport.
Because snc vbm cells accumulate vesicles and secrete
invertase in a differential manner, one possible explana-
tion is that the VBM genes mediate trafficking of two dif-
ferent types of carrier vesicles. If so, crosses between vbm1
and vbm2 mutants should yield segregants that have both
trafficking pathways coupled. To test this, we crossed snc
vbm1 and snc vbm2 cells, sporulated the diploids (in the
presence of a plasmid that expresses SNC1, which is re-
quired for sporulation), and dissected the resulting tetrads.
The results from tetrad analysis demonstrate that segre-
gation of the invertase secretion-deficient phenotype was
2:2, while that for the growth on YPD and the resistance to
temperature was 3:1, in the absence of Snc1 protein ex-
pression (data not shown). Thin-section microscopy of the
segregants obtained from a representative tetrad is shown
in Fig. 4. Phenotypic analysis and complementation re-
vealed that one segregant was snc null (a); one was snc
Figure 3. Accumulation of vesicles in v-SNARE bypass mutants.
snc vbm cells were harvested in log phase, fixed, and subjected to
thin-sectioning and electron microscopy. Representative cells are
shown. a shows a snc vbm1 cell, whereas b shows a snc vbm1 cell
that expresses SNC1 constitutively from a single-copy plasmid. c
shows a snc vbm2 cell, whereas d shows a snc vbm2 cell that ex-
presses SNC1 from a single-copy plasmid. Bars, 1 mm.
Figure 4. Accumulation of vesicles in segregants derived from
vbm1 3 vbm2 crosses. Haploid segregants derived crosses be-
tween snc vbm1 and snc vbm2 cells, obtained from tetrad analy-
sis, were processed for electron microscopy. Segregants derived
from one tetrad are shown. (aÐd) Representative cells of each
segregant. a is snc null, b is snc vbm1 vbm2, c is snc vbm2, and d is
snc vbm1, based upon phenotypic and complementation analyses.
Bars, 1 mm.David et al. v-SNARE-independent Exocytosis in Yeast 1173
vbm1 (d); one was snc vbm2 (c); whereas one was identical
to wild-type cells and was snc vbm1 vbm2 (b). Specifically,
the segregants shown in a, c, and d had the same pheno-
types described previously, while that in b was found able
to grow on YPD and at 378C, secreted invertase normally
(data not shown), and did not accumulate secretory vesi-
cles. Thus, the presence of both vbm mutations in the snc
null background appears to restore these cells to the wild-
type state.
snc and sec6 Cells Accumulate the Same Two Types of 
Exocytic Vesicles
Snc proteins appear to mediate the trafficking of two dis-
tinct types of secretory vesicles, one containing invertase
that is likely to accumulate in the bud and one lacking in-
vertase that accumulates both in the mother and bud. Re-
cent work by Harsay and Bretscher (1995) proposed, in
fact, that yeast have two types of secretory vesicles: one of
high density, which contains invertase and acid phos-
phatase; and one of lower density that contains the plasma
membrane H1-ATPase, Pma1. These two different vesicle
populations were found to accumulate in a temperature-
shifted sec6 mutant and were separated physically by den-
sity gradient centrifugation.
To determine whether snc cells also accumulate two dif-
ferent types of vesicles, as predicted by our analysis of the
snc vbm mutants, we performed density gradient centrifu-
gation of membrane preparations (100,000 g spins) from
sec6 cells that had been shifted to nonpermissive tempera-
tures for 1Ð2 h and snc cells, which accumulate vesicles
constitutively. Fractions collected from the gradient were
analyzed for acid phosphatase, invertase, ATPase, and
exoglucanase activities, using standard assays. We found
that  sec6 cells accumulate acid phosphatase, invertase
(data not shown), and exoglucanase in the high density
secretory vesicles (HDSVs), as first described by Harsay
and Bretscher (1995; Fig. 5 A). Additionally, we were able
to detect ATPase activity in the low density secretory vesi-
cles (LDSVs). In contrast to the previous study, we found
that the majority of exoglucanase activity purified with the
HDSV population, instead of being distributed amongst
both populations. Identical results were also obtained
from  sec9-4  cells (data not shown).
Fractionation of secretory vesicles from snc cells yielded
similar results to those obtained with sec6 (Fig. 5 B). Two
distinct populations of vesicles having different densities
and biochemical contents were identified, and corre-
sponded exactly with those obtained from sec6 cells. Thus,
the disruption of vesicle trafficking is similar between the
sec6 and snc mutants, showing that the blocks in secretion
competence are similar. This demonstrates that the Snc
v-SNAREs mediate the trafficking of both vesicle popula-
tions, as suggested by previous studies (Protopopov et al.,
1993; Couve and Gerst, 1994; Gerst, 1997; this study, see
Figs. 1 A and 3). Furthermore, Western blot analysis of the
fractions obtained from density gradient centrifugation re-
veal that Snc1 and Snc2 both reside on the LDSVs and
HDSVs prepared from either sec6 or sec9 cells (data not
shown).
Figure 5. Nycodenz gradient
separation of secretory vesi-
cles from sec6 and snc cells.
Secretory vesicles were ob-
tained from temperature-
shifted (378C) and non-
shifted  sec6 cells (A) and
from  snc cells (B) maintained
continuously at 288C, as de-
scribed under Materials and
Methods. Vesicles were frac-
tionated by density gradient
centrifugation over 15Ð30%
Nycodenz gradients. Den-
sity, protein concentration,
and the activities of various
enzymes in each fraction
were assayed and plotted.
The results of representative
experiments are shown. Acid
phosphatase and exogluca-
nase activities are expressed
in arbitrary units based upon
the absorbance measured at
415 nm. ATPase activity is
expressed in arbitrary units
based upon the absorbance
measured at 820 nm.The Journal of Cell Biology, Volume 143, 1998 1174
v-SNARE Bypass Mutants Accumulate One Population 
of Vesicles
Because snc null cells accumulate two distinct populations
of vesicles, it was necessary to determine whether the snc
vbm cells accumulate only one vesicle type each, as might
be predicted by the invertase secretion and electron mi-
croscopy data. We made vesicle preparations from snc
vbm1 or snc vbm2 cells and separated them on Nycodenz
density gradients as described above (Fig. 6). In addition,
samples from the different fractions were stained with ura-
nyl acetate and visualized by electron microscopy to deter-
mine the nature of the membranes that accumulate within
the VBM mutants.
We found that only one population of vesicles could be
identified in vbm2 cells. This population fractionated at
the lower density and was found to contain the membranal
H1-ATPase activity, as well as, low amounts of exoglu-
canase activity (Fig. 6 A). In contrast, no significant level
of acid phosphatase, exoglucanase, and invertase (not
shown) activities were detected at the density correspond-
ing to the HDSVs (Fig. 6 A). We did note, however, that
the single LDSV population eluted at a slightly lower av-
erage density than that found previously in sec9 or snc
cells (e.g., 1.149 vs. 1.155 g/ml Nycodenz, respectively).
Uranyl acetate staining of the membranes that fraction-
ated with the ATPase activity revealed that they consist of
a relatively uniform population of 90Ð120-nm vesicles (Fig.
6 C), as predicted earlier by the thin-section data (Figs. 3
and 4).
Similarly, only one population of vesicles could be iden-
tified in vbm1 cells. However, this population fractionated
at a significantly lower average density than that typical
for HDSVs (e.g., 1.152 vs. 1.177 g/ml), and was found to
contain high levels of both invertase and exoglucanase ac-
tivities, along with detectable ATPase activity (Fig. 6 B).
The membranes that accumulated in these fractions were
also shown by uranyl acetate staining to consist of a rela-
tively uniform population of 90Ð120-nm vesicles (Fig. 6 C),
as predicted above (Figs. 3 and 4), and did not show the
broken membranes and microsomal structures ($200 nm)
found in the early fractions of the gradient (data not
shown) and that bear typical ER and Golgi markers (see
below). These results seem to imply that each VBM accu-
mulates only one type of secretory vesicle, but may also
suggest that the density and cargo content of the vesicles
may be altered as a result of mutations in the VBM genes.
Figure 6. Nycodenz gradient
separation of secretory vesi-
cles from vbm1 and vbm2
cells. Secretory vesicles from
snc vbm2 (A) and snc vbm1
(B) mutants grown continu-
ally at 288C were isolated us-
ing Nycodenz density gradi-
ent centrifugation. Density,
protein concentration, and the
activities of various enzymes in each fraction were assayed. The results of representative experiments are shown. Acid phosphatase and
exoglucanase activities are expressed in arbitrary units based upon the absorbance measured at 415 nm. ATPase activity is expressed in
arbitrary units based upon the absorbance measured at 820 nm. Invertase activity is expressed in arbitrary units, based upon absorption at
540 nm. C Shows uranyl acetate-stained membrane from the peak enzymatic fractions derived from either vbm1 or vbm2 cells. It
should be noted that these vesicles assume a more spherical shape (e.g., as seen right corner of the vbm2 panel) when examined at lower
concentrations of material (data not shown). Crowding during the concentration and visualization procedures appears to distort the ap-
pearance of these membranes. Bar, 100 nm.David et al. v-SNARE-independent Exocytosis in Yeast 1175
Cloning of the VBM Genes
To clone the VBM genes, we first dissected tetrads ob-
tained from crosses between the individual snc vbm mu-
tants and wild-type cells. We were unable to find any hap-
loid segregants that had sensitivity to either temperature
or YPD. Thus, the presence of vbm mutations in a wild-
type background did not confer an obvious phenotype. It
is unlikely, then, that the VBM genes would have been
identified in the original sec mutant screen (Novick et al.,
1980). Similarly, haploid segregants obtained from crosses
of snc vbm1 and snc vbm2 cells also revealed no synthetic
phenotype and resulted in a 3:1 segregation of the suppres-
sor activity (described above).
We cloned VBM1 by screening snc vbm1 cells with ge-
nomic libraries carried on single-copy plasmids, in order to
isolate plasmids that conferred the snc phenotype (inabil-
ity to grow at 378C or on YPD). Out of 30,000 trans-
formants, one was temperature- and YPD-sensitive in a
plasmid-dependent manner (Fig. 7 A). Sequence analysis
revealed that this plasmid contained sequence from chro-
mosome XII and restriction mapping of the complement-
ing activity showed that it corresponded to the SUR4/
APA1/ELO3  gene (these data are available from Gen-
Bank/EMBL/DDBJ under accession number X78326; Des-
farges et al., 1993; Garcia-Arranz et al., 1994; Silve et al.,
1996; Oh et al., 1997). This was verified by creating a
frame-shift mutation in SUR4/VBM1 that terminates tran-
scription and testing the ability of the mutated gene to
complement the snc vbm1 mutation. This mutant was
found to be unable to confer complementation (Fig. 7 A).
Finally, the targeted disruption of SUR4/VBM1 in snc cells
was found to confer resistance to both temperature and
YPD (Fig. 7 A).
Vbm1/Sur4/Apa1/Elo3 is a protein of 345 amino acids
that has five putative transmembrane domains (Garcia-
Arranz et al., 1994; Silve et al., 1996). Cells bearing muta-
tions in APA1 were isolated as mutants in which Pma1 lev-
els were greatly reduced (Garcia-Arranz et al., 1994),
whereas  SUR4 was identified as a gene, which when inacti-
vated, allows yeast to become resistant to mutations in the
RVS161 gene (Desfarges et al., 1993) and to inhibitors of
the ergosterol biosynthetic pathway (Silve et al., 1996).
The mechanism by which mutations in SUR4 suppresses
the toxicity of these drugs is unknown. More recently, the
ELO3 gene was identified as encoding a protein that par-
ticipates in the elongation of LCFAs, leading to ceramide
and sphingolipid synthesis (Oh et al., 1997).
Because the yeast genome encodes two proteins with
structural homology to Vbm1/Fen1/Gns1/Elo2 (these data
are available from GenBank/EMBL/DDBJ under acces-
sion number X59720; El-Sherbeini and Clemas, 1995; Oh
et al., 1997) and Elo1 (accession number Z49471; Toke
and Martin, 1996), we tested whether either could comple-
ment the vbm2 mutation. We found that FEN1/GNS1/
ELO2 expression from either single or multi-copy plas-
mids was able to complement the vbm2 mutation (Fig. 7
B), suggesting that it is allelic to VBM2. This was verified
by the gene-targeted disruption of FEN1/GNS1/ELO2 in
snc cells, which conferred both temperature-resistance and
growth on YPD (Fig. 7 B). As the ELO2 gene product was
also demonstrated to participate in LCFA elongation
leading to sphingolipid synthesis (Oh et al., 1997), this re-
sult was not entirely unexpected.
The study by Oh et al. (1997), demonstrated that Elo2/3
act downstream of Elo1 and catalyze the elongation of
C22-containing fatty acids to LCFAs of 24 and 26 carbons,
respectively. LCFAs are required for the subsequent syn-
thesis of ceramide and the three types of inositol-contain-
ing sphingolipids in yeast: inositol-phosphorylceramide
(IPC), mannose inositol-phosphorylceramide (MIPC), and
mannose (inositolphosphoryl)2-ceramide (M(IP)2C) (re-
viewed by Lester and Dickson, 1993). Interestingly, Elo2/3
were shown to confer partially overlapping functions, as
ceramide and inositol sphingolipid synthesis were not
completely abolished by the disruption of either gene and
had little effect upon cell growth. In contrast, disruption of
both genes resulted in a loss of sphingolipid synthesis and
had a lethal phenotype. Thus, the VBM1 and VBM2 genes
identified in this study encode structural and functional
homologues involved in fatty acid and sphingolipid syn-
thesis.
Figure 7. Complementation of the vbm mutations by SUR4 and
GNS1. (A) snc vbm1 cells (JG8R-A14) were transformed with
single-copy plasmids expressing: genomic DNA from chromo-
some XII (YCpORF369-373); and VBM1 under the control of ei-
ther its native promoter (YCpSUR4) or a constitutive promoter
(YCpADH-SUR4). Cells were also transformed with 2 m plas-
mids expressing VBM1 ( pADH-VBM1) and VBM1 bearing a
frame-shift mutation (pADH-SUR4FS), under the control of a
constitutive promoter. In addition, snc vbm1 cells bearing a con-
trol plasmid, snc cells, and snc cells bearing a disruption in
VBM1/SUR4 (snc sur4::TRP1) are shown. For A and B, all cells
contained a galactose-inducible SNC1 gene and were examined
for their ability to grow on YPD or on SC at 25 and 378C. (B) snc
vbm2 cells (JG8R-A10) were transformed with plasmids express-
ing: HA-taggedVBM2/GNS1  from a single-copy plasmid
(YCpGNS1HA); VBM2/GNS1 from a multi-copy plasmid
(YEpGNS1), or a control plasmid. In addition, snc cells and snc
cells bearing a disruption in VBM2/GNS1 (snc gns1::LEU2) are
shown.The Journal of Cell Biology, Volume 143, 1998 1176
Vbm1/Elo3 and Vbm2/Elo2 Localize to the ER
A likely site of action for Vbm1/2 would be on the sepa-
rate vesicle populations, however, LCFA, ceramide, and
sphingolipid synthesis have been proposed to occur princi-
pally at the level of the ER (reviewed by Lester and Dick-
son, 1993). Thus, it was necessary to determine where
Vbm1/Elo3 and Vbm2/Elo2 reside in yeast and whether
they are present on secretory vesicles. Elo1, a homologous
protein involved early in LCFA synthesis, was previously
noted to have a KKXX motif at the 26 position from the
COOH terminus, which was proposed to act as a possible
ER-retention signal (Toke and Martin, 1996). Interest-
ingly, Vbm1/Elo3 has three consecutive putative KKXX
motifs beginning at positions 237, 233, and 229 from the
COOH terminus. This motif is lacking in Vbm2/Elo2,
however, several of the lysines are positionally conserved
and a string of basic residues (HRRKR) is present.
To test whether the Vbm proteins could be ER- or
Golgi-localized, or whether they are present on secretory
vesicles, we created tagged forms of the proteins, Vbm1HA
and Vbm2HA, which bear an HA epitope at their COOH
termini and which complement snc vbm1 and snc vbm2
cells, respectively (Fig. 7 B and data not shown). By im-
munofluorescence, we found that both Vbm1HA and
Vbm2HA localize to areas in the cell that correspond to
the ER, when expressed from either single-copy or multi-
copy vectors (Fig. 8 A and data not shown). The labeling
of Vbm1HA (Fig. 8 A) and Vbm2HA (Fig. 8 B) was pe-
ripheral to the nucleus, yielding ring-like structures that
corresponded to that of a typical ER resident protein,
Dpm1 (Fig. 8 C). Moreover, the labeling of Vbm1 or 2 was
neither similar to, nor could colocalize extensively with,
the Golgi marker Mnn1 (Fig. 8, D and E, respectively). Fi-
nally, Vbm proteins did not show a staining pattern corre-
sponding to Sso t-SNAREs (Fig. 8 F), which serve as
markers of the plasma membrane.
Subcellular fractionation also supports the probability
of ER localization. Fractionated temperature-shifted sec9-4
cell preparations (which yield both LDSV and HDSV
populations), show that neither Vbm1HA nor Vbm2HA
copurified to a large extent with the vesicles, but eluted
primarily in the initial fractions of the gradient (data not
shown). This corresponded to the localization of various
resident ER and Golgi proteins: Kar2 (Harsay and Bret-
scher, 1995), Wbp1, Sec22 (an ER-Golgi v-SNARE),
Mnn1, and Emp47 (data not shown). In contrast, the Snc
v-SNAREs and plasma membrane proteins, Sso1/2 and
Gas1, and the secreted protein, Hsp150, were found to
fractionate along the entire length of the gradient, and
were enriched in the later fractions (data not shown).
The results from these complimentary strategies suggest
a probable ER and, perhaps, early Golgi localization for
the Vbm proteins. Given this, and our inability to detect
significant amounts of the proteins on the secretory vesi-
cles, suggests that their actions upon vesicle docking and
fusion are probably exerted in a distal fashion.
v-SNARE Bypass Mutants Show Altered Levels of PI 
and Sphingolipids
We next determined whether the vbm mutations isolated
in our genetic screen also affect the synthesis of sphin-
golipid. To do so, we labeled yeast with 3H-myo-inositol,
extracted the cellular lipid, and separated the inositol-con-
taining lipids (phosphoinositides and sphingolipids) by
thin-layer chromatography. The results from a representa-
tive experiment are shown in Fig. 9.
Figure 8. Localization of
Vbm proteins by indirect im-
munofluorescence and confo-
cal microscopy. sec9-4 cells
expressing Vbm1-HA from a
multi-copy plasmid (a, c ,  d,
and e) and Vbm2-HA from a
single-copy plasmid (b) were
grown under permissive con-
ditions and fixed for immu-
nofluorescence. Cells were
labeled with preadsorbed, af-
finity-purified anti-HA (1:1,000;
a, b, and e), anti-Dpm1 (3.3
mg/ml; c), anti-Mnn1 (1:10; d
and e), or anti-Sso (1:100; f)
antisera. FITC-conjugated
goat antiÐmouse (a, b, c, and
e) and antiÐrabbit (d and f),
as well as rhodamine-conju-
gated goat antiÐrabbit (e)
secondary antibodies were
used. Nuclear staining with
propidium iodide is shown in
a (beneath white line), d, and
f. Cells were visualized by
confocal microscopy.David et al. v-SNARE-independent Exocytosis in Yeast 1177
First, the level of phosphoinositide (PI) synthesized in
snc cells was ,40% of wild-type cells (Fig. 9 A). This prob-
ably reflects the reduced cellular metabolism and growth
rate of snc cells (Protopopov et al., 1993; Gerst, 1997; data
not shown). In contrast, snc cells bearing recessive muta-
tions in the VBM genes, which were isolated in the VBM
screen, showed elevated levels of PI. PI levels in vbm1 and
vbm2 cells were 40 and 80% higher, respectively, than
those of wild-type cells and at least three- to fourfold
higher than those of snc null cells. This initially suggested
that PI levels might influence the viability of snc yeast.
However, we found that snc yeast bearing targeted disrup-
tions in the VBM genes, while phenotypically identical to
the vbm recessive mutants (Fig. 7, A and B), did not have
greatly elevated levels of PI (Fig. 9 A and data not shown).
In four similar experiments, we found that the levels of PI
tended to be twofold over the levels of snc yeast, but 20%
less than that of wild-type cells (data not shown). These
differences indicated that the vbm mutations isolated by
genetic screening behave somewhat differently than the
targeted gene knockouts and may not fully inactivate Vbm
function.
The levels of sphingolipid synthesized in snc cells were
also reduced vis a vis wild-type cells. Reductions in IPC,
MIPC, and M(IP)2C levels by z60% were detected (Fig. 9
A), although no significant change in the ratio of IPC to
MIPC or M(IP)2C, was seen relative to wild-type cells (the
ratios in both cell types being z4:1 and 25:1, respectively;
n 5 4 experiments; Fig. 9 B). This reduction in sphin-
golipid synthesis also corresponds with the reduced me-
tabolism and growth of the snc null strain.
Mutation in, or disruption of, either ELO/VBM gene
was found to affect the levels of sphingolipid in both wild-
type and snc yeast (Oh et al., 1997 and this study). As first
shown by Oh et al. (1997), the levels of inositol sphingolip-
ids are reduced significantly by the disruption of either
ELO2 or ELO3 in wild-type cells, although the amount of
IPC remained at wild-type levels or higher in elo3D cells.
In the snc background, we also found that the levels of
IPC were elevated as a result of either vbm1 mutation
(.400%) or vbm1::TRP1 deletion (1130%; Fig. 9 A), and
constituted .90% of the bulk sphingolipid present (n 5 4
experiments; Fig. 9 B). In contrast, the amount of MIPC
and M(IP)2C was almost undetectable (,5% of that found
in wild-type and snc cells; Fig. 9 A). The IPC:MIPC ratio
in vbm1 and vbm1::TRP1 cells was found to be 52:1 and
31:1, respectively, in this experiment. Thus, mutations in
VBM1/ELO3 appear to result in the accumulation of IPC
in the cell, probably at the expense of the mannosylated
sphingolipids, MIPC and M(IP)2C. This, along with the
work of Oh et al. (1997), suggests that the C26 LCFAs may
be necessary for the generation of mannosylated sphin-
golipids.
Similar to that shown by Oh et al. (1997) for the disrup-
tion of ELO2, we also found that mannosylated sphin-
golipids, MIPC and M(IP)2C, were present in lipid extracts
from  vbm2  and  vbm2::LEU2 cells. Their levels were
,40% of wild-type levels, but were fourfold higher (on av-
erage) than those of the vbm1 and vbm1::TRP1 strains (n 5
3 experiments; Fig. 9 B). Correspondingly, there was a de-
crease in the level of IPC by .60 and 85% in the vbm2 and
vbm2::LEU2 strains, respectively, relative to wild-type
cells (Fig. 9 A). The IPC:MIPC ratio in vbm2 and vbm2::
LEU2 cells was 7:1 and 6:1, respectively; n 5 4 experi-
ments.
These experiments suggest that snc vbm1 and snc vbm2
mutants have elevated levels of PI and reductions in cer-
tain sphingolipids, relative to wild-type cells. The effects
upon sphingolipid levels are highly similar to those shown
previously for the disruption of ELO2 or 3 in wild-type
cells and also by us for their disruption in sec6-4 and SP1
wild-type cells (Sundarababu, S., and J.E. Gerst, unpub-
lished results). More importantly, they imply that the abil-
ity of the recessive mutations to confer the v-SNARE by-
pass effect is related to the role of the Vbm proteins in
LCFA/sphingolipid synthesis and not via an unrelated
function.
Deletion of Either VBM1 or VBM2 in
Wild-type or sec6 Cells Does Not Significantly Alter 
Protein Trafficking
Because mutations in the VBM/ELO genes affect protein
trafficking in cells lacking the Snc v-SNAREs, it was of im-
portance to determine whether they also affect protein
trafficking and secretion in either wild-type or sec yeast.
We first examined whether disruption of the VBM/ELO
genes affected cell growth. According to the study of Oh et
al. (1997), these disruptions reduced the rate of cell growth
somewhat. In contrast, we were unable to see any signifi-
Figure 9. Sphingolipid syn-
thesis is deficient in v-SNARE
bypass mutants. Yeast strains
including: SP1 wild-type cells;
JG8 snc null cells; JG8R-A14
snc vbm1 cells; JG8R-a10 snc
vbm2 cells; DD1 snc vbm1::
TRP1  cells; and SS1 snc
vbm2::LEU2 cells were la-
beled with [3H]myo-inositol,
as described under Materials
and Methods. Aliquots from
extracted cells were sepa-
rated by thin-layer chroma-
tography and visualized by
phosphorimager analysis. A
Shows the quantitative trac-
ing of a representative exper-
iment, where PI indicates
phosphatidylinositides; IPC
indicates inositolphosphoryl-
ceramide;  MIPC indicates
mannose inositolphosphoryl-
ceramide; and M(IP)2C indi-
cates mannose (inositolphos-
phoryl)2-ceramide.  B Shows
the relative percentages of
sphingolipid within a given
strain, as determined from
three or four similar experi-
ments. Error bars indicate
the standard error of the
mean.The Journal of Cell Biology, Volume 143, 1998 1178
cant difference in the growth rates of either wild-type or
sec6 cells bearing disruptions in either VBM1/ELO3  or
VBM2/ELO2, nor was the temperature sensitivity in the
sec6 background affected (data not shown). Some minor
morphological changes were noted and will be described
elsewhere.
To test whether protein trafficking in these cells is af-
fected, we examined the secretion of invertase and media
proteins, as well as, the processing of CPY, invertase, and
Gas1 therein. We found that invertase secretion from cells
bearing VBM1/ELO3 or VBM2/ELO2 disruptions in ei-
ther the wild-type or sec6 background was identical to con-
trol wild-type or sec6 cells, respectively (data not shown).
In temperature-shifted cells (378C), no blockage or alter-
ation in the intracellular accumulation of invertase was de-
tected. Likewise, disruption of VBM1/ELO3  or  VBM2/
ELO2 in the wild-type or sec6 backgrounds did not alter
the secretion of proteins into the medium, as shown by
metabolic labeling studies (data not shown). Finally, the
processing of CPY and invertase in these cells was identi-
cal to that shown for wild-type cells (Fig. 2, A and B),
whereas that of Gas1 was delayed, as shown above for snc
vbm cells (data to be presented elsewhere). Thus, disrup-
tion of the individual VBM genes in either a wild-type or
sec6 background had no deleterious effects upon general
protein processing and secretion.
At restrictive conditions (378C), secretory vesicles were
found to accumulate in sec6 cells bearing disruptions in ei-
ther VBM1/ELO3 or VBM2/ELO2, as assessed by elec-
tron microscopy (Shinder, V., and J.E. Gerst, data not
shown). Density gradients performed using membranes
derived from temperature-shifted sec6 vbm1::LEU2 and
sec6 vbm2::LEU2 cells did not reveal significant changes
in the biochemical identity and distribution of the LDSV
and HDSV populations (data not shown). Thus, we sug-
gest that disruption of VBM1 or VBM2 in a wild-type
background does not alter vesicle biogenesis or protein se-
cretion.
In contrast, we found that disruption of either VBM1/
ELO3  or  VBM2/ELO2  in the snc null  background did
ameliorate protein secretion and processing in the same
manner as described above for the snc vbm cells isolated
in the genetic screen (data to be presented elsewhere).
This result was predicted from the genetic complementa-
tion and inositol labeling experiments shown above (Figs.
7 and 9, respectively).
v-SNARE Bypass Mutants Do Not Bypass the
t-SNARE Requirement in Exocytosis
To determine whether VBM cells bypass the known
t-SNARE requirement in secretion, we disrupted either
VBM1 or VBM2 in yeast lacking both Snc v-SNAREs and
the Sso1 t-SNARE (Aalto et al., 1993), but bearing a tem-
perature-sensitive mutation in the other syntaxin homo-
logue, Sso2 (Aalto et al., 1993). Previously, we found that
cells bearing both snc null mutations and a temperature-
sensitive mutation either in SEC9 (sec9-4) or SEC17
(sec17-1) are inviable, indicating that a fully functional
Sec9 t-SNARE and Sec17 are required in yeast lacking the
Snc v-SNAREs (Couve and Gerst, 1994; Gerst, 1997). For
this study, we found that combined snc null and sso1D
sso2-1 mutations also lead to inviability (synthetic lethal-
ity), which is suppressed by the expression of SSO1, SSO2,
or SNC2 (Fig. 10). Thus, results obtained here with the
mutant Sso2 t-SNARE are identical to those shown previ-
ously for the mutant Sec9 t-SNARE and Sec17 a-SNAP
homologue.
We conjectured that if vesicle trafficking in snc vbm
cells is conferred in a t-SNARE-independent fashion, then
the Sso t-SNAREs should be dispensable for function. To
test this hypothesis, either VBM1 or VBM2 were disrupted
in sncD sso1D sso2-1 cells, which bear a plasmid that ex-
presses SNC2 from a galactose-inducible promoter and
which were maintained on galactose. Next we examined
the viability of these yeast by replica plating patches of
cells onto glucose-containing plates (Fig. 10). We found
that sncD sso1D sso2-1 vbm1D (Fig. 10) and sncD sso1D
sso2-1 vbm2D (not shown) cells remained inviable in the
absence of SNC2 gene expression. Thus, an intact and
fully functional Sso protein is indispensable in snc vbm
cells, implying that vesicle docking and fusion therein is
t-SNARE dependent.
Discussion
Are v-SNAREs Essential for Exocytosis?
According to the SNARE hypothesis, interactions be-
tween v-SNAREs on vesicles and t-SNAREs on target
membranes result in SNARE complex formation, allowing
for membrane fusion to occur (reviewed in Rothman and
Warren, 1994). Therefore, mutations that result in the in-
activation, or loss of expression, of either v- or t-SNAREs
should block membrane fusion at their specific sites of ac-
tion. In support of this tenet, it was shown that deletions in
yeast genes encoding the individual v- and t-SNAREs in-
volved in ER-Golgi transport (i.e., Bet1, Bos1, and Sed5),
as well as, the t-SNAREs involved in exocytosis (i.e., Sec9,
Sso1 and Sso2 together) result in lethality (Dascher et al.,
1991; Shim et al., 1991; Newman et al., 1992; Hardwick et al.,
1992; Brennwald et al., 1994; Aalto et al., 1993). Studies on
Figure 10. t-SNARE dependence of v-SNARE bypass mutants.
snc sso1D sso2-1 cells transformed with a control plasmid (con-
trol) or with plasmids expressing SSO1 or SSO2 under control of
the ADH1 promoter (ADH-SSO1 and ADH1-SSO2) were tested
for viability on synthetic medium containing galactose (SC GAL)
or glucose (SC GLU), or on amino acidÐrich medium (YPD). snc
sso1D sso2-1 cells bearing a disruption of VBM1 (snc sso1D sso2-1
vbm1::TRP1) were tested alongside. All cells carry the pAH-
GAL-SNC2 plasmid, which expresses SNC2 under the control of
a galactose-inducible promoter, and maintains the cellular viabil-
ity of the snc sso1D sso2-1 strain on galactose-containing medium.
Cells were grown on SC GAL at room temperature before rep-
lica plating onto SC GAL, SC GLU, and YPD for 2 d at 268C.David et al. v-SNARE-independent Exocytosis in Yeast 1179
higher organisms also tend to support this idea. For exam-
ple, the targeted expression of tetanus toxin in Drosophila
embryos results in the loss of evoked neurotransmitter re-
lease, presumably resulting from the inactivation of one of
the synaptobrevin isoforms (n-syb; Sweeny et al., 1995).
The presence in these embryos of syb-a, an ubiquitously
expressed isoform, as well as synaptotagmin, a synaptic
vesicle protein that bears v-SNARE-like qualities (Schi-
avo et al., 1995, 1997) may prevent defects in embryogene-
sis from occurring.
In contrast to the idea that v-SNAREs are essential, we
have characterized yeast that bypass the v-SNARE re-
quirement in constitutive secretion. Yeast lacking the SNC
genes, which encode redundant v-SNAREs of the exocytic
pathway, were originally shown to be viable under certain
conditions (Protopopov et al., 1993). This suggested that
they are required only for efficient exocytosis, or that an
unknown v-SNARE is present on secretory vesicles. The
latter possibility seems remote for several reasons. First,
other than SNC1 or SNC2, no other v-SNARE was iso-
lated in multicopy suppression screens of the snc pheno-
type. Second, overexpression of other yeast v-SNAREs
could not suppress the defects in snc yeast. Third, deletion
of the SNC genes in certain wild-type strains was found to
be lethal (Gerst, J.E., unpublished data). The differences
between strain backgrounds are unclear, however, a simi-
lar phenomenon was demonstrated for the CHC1 gene,
which encodes clathrin heavy chain (Payne and Schekman,
1985; Lemmon and Jones, 1987; Munn et al., 1991). Since
snc null cells show a conditional lethal phenotype and are
restored to full viability by recessive (and inactivating)
mutations, it seems likely that the exocytic v-SNAREs are
not essential for secretion, but do allow for more efficient
vesicle docking and fusion.
This idea is supported by studies on vacuolar membrane
fusion that show that the v-SNARE (Nyv1) is dispensable,
in part, for the formation of vacuoles in vivo and mem-
brane fusion in vitro (Nichols et al., 1997). It is also sup-
ported by a recent study that shows that the Ufe1 t-SNARE
is sufficient to confer ER membrane fusion (Patel et al.,
1998). In this study, we find that mutations in the VBM
genes allow for the bypass of the v-SNARE requirement
in exocytosis. However, they do not confer a bypass of the
t-SNARE requirement, as a fully functional Sso protein is
required for viability (Fig. 10). This suggests that a protein
with SNARE-like functions may be present on secretory
vesicles and can partner efficiently with Sec9 and Sso, in
the absence of Snc protein. Based upon the studies of
Nichols et al. (1997) and Patel et al. (1998), the likely can-
didates for such a function are the Sso t-SNAREs them-
selves, although this remains to be formally proven. Alter-
natively, missorting of a v-SNARE originating from an
earlier compartment might also be capable of conferring
fusion, provided it could interact productively with the Sso
proteins.
VBM1 and 2 Encode ER-localized
Membrane Proteins That Act upon LCFA, Ceramide, 
and Sphingolipid Synthesis
In our search for genes that restore secretion and normal
cell growth in snc cells, we isolated revertants that bear
mutations in genes designated here as VBM1 and VBM2.
These genes were characterized by another group (desig-
nated therein as ELO2 and 3) and were shown to encode
proteins involved in the elongation of LCFAs and subse-
quent synthesis of inositol-containing sphingolipids (Oh
et al., 1997). We have shown that these Vbm/Elo proteins
localize to the ER (Fig. 8), the proposed site of ceramide
and sphingolipid synthesis, and that their inactivation
leads to the v-SNARE-bypass phenotype (Fig. 7). Thus,
we demonstrate a genetic relationship between genes in-
volved in ceramide/sphingolipid metabolism and the regu-
lation of cellular secretion.
Earlier studies implicated these same genes in the regu-
lation of membrane trafficking. For example, mutations in
SUR4 were shown originally to suppress defects that result
from the disruption of the RVS161/END6 gene in yeast
(Crouzet et al., 1991; Desfarges et al., 1993; Munn et al.,
1995). The gene product from RVS161/END6 is involved
in endocytosis and is homologous to amphiphysin (David
et al., 1994; Sivadon et al., 1995), a vesicle-associated pro-
tein that participates in synaptic vesicle endocytosis in
mammals (Schupiakov et al., 1997). How mutations in
SUR4/VBM1/ELO3 restore the viability of rvs161 mutants
remains unknown, but it suggests a possible role for Sur4/
Vbm1/Elo3 in the endocytic trafficking of vesicles. Addi-
tional support for the idea that ceramide and sphingolipid
synthesis may play a role in endocytosis is the finding that
another end mutant, end8, is allelic to the lcb1 gene, that
encodes the serine palmitoyltransferase activity that con-
tributes to sphinganine and ceramide synthesis (Stterlin
et al., 1997). Thus, other studies using yeast have impli-
cated these lipids in essential trafficking events.
The precise mechanism by which inactivating mutations
in the VBM/ELO genes restore cellular secretion from snc
cells remains unclear. Since Vbm1/2 localize to the ER and
not to secretory vesicles, and were shown to act upon
LCFA and sphingolipid synthesis (Oh et al., 1997 and this
study), they appear to mediate the docking and fusion of
secretory vesicles in a distal fashion. It is not clear whether
such regulation exists in wild-type cells or is revealed only
in the context of the snc null background, where the fusion
competence of vesicles is challenged. Our examination of
VBM1/ELO3  or  VBM2/ELO2  gene disruption in wild-
type or sec6 cells indicates, thus far, that the secretion of
invertase and media proteins is not significantly affected,
and does not block biogenesis of the two types of vesicles
(data not shown).
On the basis of these results, we suggest that reduced
functioning of the Vbm/Elo proteins is necessary and suffi-
cient to lead to the v-SNARE bypass phenotype and a res-
toration in secretion (Fig. 1). This occurs without ad-
versely affecting the transport of vacuolar and certain
secreted proteins early in the pathway (Fig. 2). Moreover,
electron microscopy (Figs. 3 and 4) and vesicle purification
studies (Figs. 5 and 6), go so far as to suggest that each
vbm mutation might preferentially recouple transport of
one of the secretory vesicle populations found in yeast
lacking the Snc v-SNAREs. This idea is supported by ini-
tial studies of VBM/ELO gene disruption in sec6 cells,
which do not show defects in vesicle biogenesis. Should
this be borne out by further examination, then alterations
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can be said to have a direct and profound effect upon the
fusion competence of the two classes of secretory vesicles.
Labeling experiments performed with [3H]inositol dem-
onstrate that snc vbm cells have reduced levels of certain
sphingolipids (Fig. 9). This was shown originally for the
disruption of ELO2 or 3 in wild-type yeast (Oh et al., 1997
and data not shown). Thus, mutations in the VBM/ELO
genes appear to yield the same effect upon sphingolipid
synthesis, irrespective of whether the SNC genes are
present or not. The study by Oh et al. (1997) also found
that fatty acid chain length was altered as a result of muta-
tion in either ELO gene. In elo2D cells, saturated and hy-
droxy C26-fatty acids were present, whereas in elo3D, cells
saturated and hydroxy C22-fatty acids were prominent. Be-
cause the effects of VBM/ELO mutation upon sphin-
golipid synthesis are independent of strain background, we
expect that chain length is affected similarly in snc vbm
cells. Thus changes, or a series of changes, in fatty acid
chain length, ceramide and sphingolipid composition, may
result in the enhanced trafficking of one type of vesicle
(and its cargo), relative to the other, in snc vbm cells.
While unresolved at present, the possible levels at which
chain length and sphingolipid composition might alter pro-
tein trafficking include: (a) the sorting of protein cargo
into vesicles at either early or late stages of the secretory
pathway (e.g., from the ER or trans Golgi); (b) regulation
of proteinÐprotein interactions in the sphingolipid-con-
taining bilayers; and (c) regulation of the physical charac-
teristics of the lipid bilayers, such as to either enhance or
impede fusion.
That sphingolipids participate in the selective sorting of
cargo to yield vesicles that differ in protein composition
has interesting parallels with higher eukaryotes. In mam-
malian cells, for example, sphingolipids have been sug-
gested to form separate entities involved in the apical traf-
ficking of proteins (see review by Simons and Ikonen,
1997). In yeast, others have demonstrated that sphin-
golipid synthesis is required for the sorting of GPI-
anchored proteins from the ER to the Golgi (Horvath et
al., 1994; Skrzypek et al., 1997). This may explain why the
processing of Gas1, but not CPY or invertase, is slowed in
the snc vbm mutants, which are deficient in sphingolipid
synthesis (Fig. 2). It may also explain, in part, why the den-
sities and contents of the vesicle types in snc vbm cells dif-
fer somewhat from those found in sec6 or snc cells. These
differences could, potentially, result in vesicles having an
altered ability to recruit protein cargo. This alone might
lead to a reduction in fusion competence, if a SNARE or a
protein that regulates SNARE assembly was not recruited
efficiently.
An alternative explanation is that the vbm mutations
block biogenesis of one of the vesicle types. Our view is
that this possibility is less likely. First, a distinct vesicle
population accumulates in either snc vbm mutant (Figs. 1,
3, 4, and 6), thus, another population must undergo recou-
pled transport in order to restore normal growth to snc
cells. Second, invertase undergoes maturation in vbm1
cells (Fig. 2), which would not be expected if it were accu-
mulating within the Golgi complex. Third, both popula-
tions of vesicles were found to exist in sec6 yeast that bore
disruptions in either VBM1 or VBM2 (data not shown).
There are other possible explanations, including the
idea that LCFAs and their products, ceramides and sphin-
golipids, alter the sorting or functioning of proteins in-
volved in vesicle docking and fusion (i.e., SNAREs). These
effects could be exerted at the structural level and alter the
physical properties of membranal proteins. For example,
fatty acid chain length might significantly affect membrane
thickness, thus, altering protein sorting and, perhaps, even
function. As evidence for the former, it has been shown
that the length of membrane-spanning domains can be an
important determinant for organelle retention (Munro,
1995; Rayner and Pelham, 1997). According to the lipid-
based sorting model (reviewed in Munro, 1998), a lowered
capacity for sphingolipid synthesis might result in mem-
brane thinning and, as a result, alter sorting of proteins
destined for the plasma membrane, as well as those nor-
mally retained by the Golgi complex. Similarly, we cannot
rule out the possibility that ceramides act upon signaling
processes that effect vesicle transport and fusion. For ex-
ample, ceramides have been shown to play a role in viral
entry and membrane fusion (Nieva et al., 1994), while cer-
amide analogues have been shown to reduce fluid-phase
and receptor-mediated uptake of markers in fibroblasts
(Chen et al., 1993) and in yeast (Riezman et al., 1998), sug-
gesting a probable role in endocytosis. Moreover, work in
progress in our laboratory suggests at least a partial role
for ceramides in mediating the VBM effect (Marash, M.,
and J. Gerst, unpublished results). Finally, a role for
LCFAs in the nuclear transport of mRNA and mainte-
nance of the nuclear envelope, as well as, in mitochondrial
inheritance has been suggested (reviewed in Schneiter and
Kohlwein, 1997). Therein, it was speculated that LCFAs
themselves might modulate membrane rigidity and curva-
ture. Thus, more work will be necessary in order to define
the different possible roles that LCFAs and their metabo-
lites play in membrane trafficking.
Alternate Paths to the Cell Surface in Yeast
Work by Harsay and Bretscher (1995) and us suggest that
the secretory pathway in yeast is bifurcated and that at
least two separate routes to the cell surface are used. Here,
we show that the VBM genes may be involved in the regu-
lation of the two constitutive routes, perhaps by helping to
define the conditions for protein sorting along the alter-
nate paths. Thus, the existence of two types of secretory
vesicles, which differ significantly both in nature and cargo
molecule content, implies that a high degree of specificity
is operant in the trafficking of proteins to the cell surface.
These two populations: HDSVs, which are rich in soluble
secreted enzymes, and LDSVs, which contain a membra-
nal H1-ATPase, reflect the distinct sorting determinants
(either proteinaceous or lipid) for the individual cargo
molecules. Alternatively, we should consider the idea that
these vesicles may originate from distinct post-Golgi com-
partments (i.e., one from the trans-Golgi and the other
from an intermediate or endosomal compartment). Thus,
they may represent two pools of trafficked proteins, one
purely of biosynthetic origin, while the other contributing
components recycled from the plasma membrane.
The results from these studies suggest that preferential
routes are used by individual proteins, e.g., invertase,
which accumulates in HDSVs and in the vesicles found inDavid et al. v-SNARE-independent Exocytosis in Yeast 1181
snc vbm1 cells. Yet, this may not be true for membrane
proteins that are required for essential functions. Presum-
ably, the viability of both snc vbm1 and snc vbm2 cells im-
plies that proteins essential for growth (i.e., amino acid
transporters) reach the cell surface via either route, while
nonessential cargo may be trafficked more specifically.
Given the robust condition of either vbm mutant, this hy-
pothesis would seem reasonable and is supported by the
finding that proteins are secreted into the medium equally
well by either mutant (Fig. 1 B).
Although much remains unanswered, our results suggest
that protein delivery to the cell surface is far more regu-
lated and specific than previously described. This added
level of regulation may have evolved during bifurcation of
the late secretory pathway early in eukaryote evolution
and may have given rise to the multiple trafficking paths
(i.e., apical/basolateral and constitutive/stimulus-coupled)
found in multicellular organisms.
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